InvestorInformation

Latest Annoucements

  • Disclosure of material event – Acquisition

    30.06.2022 Read More
  • Disclosure of material event

    01.06.2022 Read More
  • Disclosure of material event – Audio recording of Investors/Analysts meet

    28.05.2022 Read More
  • Q4 FY22 Investor Presentation

    27.05.2022 Read More
  • Recommendation of Final Dividend for FY 2021-22

    27.05.2022 Read More
  • Q4 FY22 Press Release

    26.05.2022 Read More
  • Q4 FY22 Results Sheet

    26.05.2022 Read More
  • Disclosure of material event – Update on Assignment of Trademark for Azmarda® indicated for heart failure patients with reduced ejection fraction (HfrEF) from Novartis AG, Switzerland for India

    13.04.2022 Read More
  • Assignment of Trademark for Azmarda® from Novartis AG, Switzerland for India

    01.04.2022 Read More
  • Disclosure of material event – Resignation of Director

    14.03.2022 Read More
  • Intimation of record date for Interim Dividend

    14.02.2022 Read More
  • Declaration of Interim Dividend for FY 2021-22

    14.02.2022 Read More
  • Q3 FY22 Press Release

    14.02.2022 Read More
  • Q3 FY22 Investor Presentation

    14.02.2022 Read More
  • Q3 FY22 Results Sheet

    14.02.2022 Read More
  • Schedule of Investors /Analysts’ call with Management on 15.02.2022 and Registration Log-in details.

    08.02.2022 Read More
  • Investor presentation in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited- 27.01.2022

    27.01.2022 Read More
  • Disclosure of material event – Resignation of Director

    27.01.2022 Read More
  • Press Release in relation to Acquisition of Brands and Related Assets from Sanzyme Private Limited

    27.01.2022 Read More
  • Disclosure of material event – Acquisition of Brands and Related Assets from Sanzyme Private Limited

    27.01.2022 Read More
  • Schedule of Investors / Analysts’ call with Management on 27.01.2022 and Registration Log-in details for the same

    26.01.2022 Read More

Financial Information

Know More

Shareholder's corner

Know More

CEO's Desk

We are BIG enough to create a positive impact for patients and healthcare providers, we are small enough to still care…

Know More

IR & Shareholders Contact

For Shareholders:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com

For Transfer/Transmission of Shares:
Datamatics Business Solutions Ltd.
Plot No. B 5, Part B Crosslane,
MIDC, Andheri (East), Mumbai 400 093.
India.

Contact Person: Mr. Satish Patil
Tel No. (022) 6671 2001-06
Fax No. (022) 6671 2011
Email: corpequity@dfssl.com

Nodal Officer for the Purpose of Coordination with IEPF Authority:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.
India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com